Olive (Olea europaea) leaf extract induces apoptosis and monocyte/macrophage differentiation in human chronic myelogenous leukemia K562 cells: Insight into the underlying mechanism

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Samet, Imen ^a   Han, Junkyu ^a   Jlaiel, Lobna ^b   Sayadi, Sami ^b   Isoda, Hiroko ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b CENTRE DE BIOTECHNOLOGIE DE SFAX   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; HEALTH CARE; MEDICINE;

ANTI-OXIDANT ACTIVITIES; CHRONIC MYELOGENOUS LEUKEMIA; DIFFERENTIALLY EXPRESSED GENE; LEAF EXTRACTS; MICROARRAY ANALYSIS; OLEA EUROPAEA; THERAPEUTIC EFFECTS; TREATMENT TIME;

CELL DEATH;

ACTEOSIDE; ANTINEOPLASTIC AGENT; APIGENIN; APIGETRIN; CHEMLALI OLIVE LEAF EXTRACT; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; EARLY GROWTH RESPONSE FACTOR 1; FOXP 1 PROTEIN; HYDROXYTYROSOL; IFI 16 PROTEIN; INTERLEUKIN 8; LUTEOLIN; LUTEOLIN 7 GLUCOSIDE; NFYA PROTEIN; OLEUROPEIN; PLANT EXTRACT; PROTEIN; UNCLASSIFIED DRUG; TRANSCRIPTOME;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL COUNT; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL DEATH; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CELL VIABILITY; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DPPH RADICAL SCAVENGING ASSAY; DRUG MECHANISM; FLOW CYTOMETRY; GENE EXPRESSION; GROWTH INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MACROPHAGE; MICROARRAY ANALYSIS; MONOCYTE; MTT ASSAY; OLIVE TREE; PLANT LEAF; CELL CYCLE CHECKPOINT; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; K562 CELL LINE; METABOLISM; PATHOLOGY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; K562 CELLS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MONOCYTES; OLEA; PLANT EXTRACTS; PLANT LEAVES; TRANSCRIPTOME;

EID: 84899998513     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/927619     Document Type: Article

References (67)

1. Leszczyniecka M., Roberts T., Dent P., Grant S., Fisher P. B., Differentiation therapy of human cancer: basic science and clinical applications. Pharmacology and Therapeutics 2001 90 2-3 105 156 2-s2.0-0034816040 10.1016/S0163-7258(01)00132-2
2. Spira A. I., Carducci M. A., Differentiation therapy. Current Opinion in Pharmacology 2003 3 4 338 343 2-s2.0-0042804927 10.1016/S1471-4892(03)00081-X
3. Nobili S., Lippi D., Witort E., Donnini M., Bausi L., Mini E., Capaccioli S., Natural compounds for cancer treatment and prevention. Pharmacological Research 2009 59 6 365 378 2-s2.0-65049089754 10.1016/j.phrs.2009.01.017
4. Ramos S., Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. Journal of Nutritional Biochemistry 2007 18 7 427 442 2-s2.0-34249882770 10.1016/j.jnutbio.2006.11.004
5. Hajhashemi V., Vaseghi G., Pourfarzam M., Abdollahi A., Are antioxidants helpful for disease prevention? Research in Pharmaceutical Sciences 2010 5 1 1 8 2-s2.0-78650642750
6. Bouaziz M., Sayadi S., Isolation and evaluation of antioxidants from leaves of a Tunisian cultivar olive tree. European Journal of Lipid Science and Technology 2005 107 7-8 497 504 2-s2.0-23944469839 10.1002/ejlt.200501166
7. Pereira A. P., Ferreira I. C. F. R., Marcelino F., Valentão P., Andrade P. B., Seabra R., Estevinho L., Bento A., Pereira J. A., Phenolic compounds and antimicrobial activity of olive (Olea europaea L. Cv. Cobrançosa) leaves. Molecules 2007 12 5 1153 1162 2-s2.0-34249865101 10.3390/12051153
8. Somova L. I., Shode F. O., Ramnanan P., Nadar A., Antihypertensive, antiatherosclerotic and antioxidant activity of triterpenoids isolated from Olea europaea, subspecies africana leaves. Journal of Ethnopharmacology 2003 84 2-3 299 305 2-s2.0-0037295681 10.1016/S0378-8741(02)00332-X
9. Micol V., Caturla N., Pérez-Fons L., Más V., Pérez L., Estepa A., The olive leaf extract exhibits antiviral activity against viral haemorrhagic septicaemia rhabdovirus (VHSV). Antiviral Research 2005 66 2-3 129 136 2-s2.0-19344373333 10.1016/j.antiviral.2005.02.005
10. Wainstein J., Ganz T., Boaz M., Bar Dayan Y., Dolev E., Kerem Z., Madar Z., Olive leaf extract as a hypoglycemic agent in both human diabetic subjects and in rats. Journal of Medicinal Food 2012 15 7 605 610 10.1089/jmf.2011.0243
11. Seddik L., Bah T. M., Aoues A., Slimani M., Benderdour M., Elucidation of mechanisms underlying the protective effects of olive leaf extract against lead-induced neurotoxicity in Wistar rats. Journal of Toxicological Sciences 2011 36 6 797 809 2-s2.0-82855180222 10.2131/jts.36.797
12. Bouallagui Z., Han J., Isoda H., Sayadi S., Hydroxytyrosol rich extract from olive leaves modulates cell cycle progression in MCF-7 human breast cancer cells. Food and Chemical Toxicology 2011 49 1 179 184 2-s2.0-78650292220 10.1016/j.fct.2010.10.014
13. Fares R., Bazzi S., Baydoun S. E., Abdel-Massih R. M., The antioxidant and anti-proliferative activity of the Lebanese Olea europaea extract. Plant Foods for Human Nutrition 2011 66 1 58 63 2-s2.0-79955057132 10.1007/s11130-011-0213-9
14. Goulas V., Exarchou V., Troganis A. N., Psomiadou E., Fotsis T., Briasoulis E., Gerothanassis I. P., Phytochemicals in olive-leaf extracts and their antiproliferative activity against cancer and endothelial cells. Molecular Nutrition and Food Research 2009 53 5 600 608 2-s2.0-66149158379 10.1002/mnfr.200800204
15. de Bock M., Thorstensen E. B., Derraik J. G., Henderson H. V., Hofman P. L., Cutfield W. S., Human absorption and metabolism of oleuropein and hydroxytyrosol ingested as olive (Olea europaea L.) leaf extract. Molecular Nutrition and Food Research 2013 57 11 2079 2085 10.1002/mnfr.201200795
16. Briante R., Patumi M., Terenziani S., Bismuto E., Febbraio F., Nucci R., Olea europaea L. leaf extract and derivatives: antioxidant properties. Journal of Agricultural and Food Chemistry 2002 50 17 4934 4940 2-s2.0-0037077381 10.1021/jf025540p
17. Benavente-García O., Castillo J., Lorente J., Ortuño A., Del Rio J. A., Antioxidant activity of phenolics extracted from Olea europaea L. leaves. Food Chemistry 2000 68 4 457 462 2-s2.0-0033991129 10.1016/S0308- 8146(99)00221-6
18. Omar S. H., Oleuropein in olive and its pharmacological effects. Scientia Pharmaceutica 2010 78 2 133 154 2-s2.0-77954643863 10.3797/scipharm.0912-18
19. Jemai H., Bouaziz M., Fki I., El Feki A., Sayadi S., Hypolipidimic and antioxidant activities of oleuropein and its hydrolysis derivative-rich extracts from Chemlali olive leaves. Chemico-Biological Interactions 2008 176 2-3 88 98 2-s2.0-55249116731 10.1016/j.cbi.2008.08.014
20. García-Villalba R., Larrosa M., Possemiers S., Tomás-Barberán F. A., Espín J. C., Bioavailability of phenolics from an oleuropein-rich olive (Olea europaea) leaf extract and its acute effect on plasma antioxidant status: comparison between pre- and postmenopausal women. European Journal of Nutrition 2013 10.1007/s00394-013- 0604-9
21. Anter J., Fernández-Bedmar Z., Villatoro-Pulido M., Demyda-Peyras S., Moreno-Millán M., Alonso-Moraga Á., Muñoz-Serrano A., Luque de Castro M. D., A pilot study on the DNA-protective, cytotoxic, and apoptosis-inducing properties of olive-leaf extracts. Mutation Research 2011 723 2 165 170 2-s2.0-79959760306 10.1016/j.mrgentox.2011.05.005
22. Sutherland J. A., Turner A. R., Mannoni P., Differentiation of K562 leukemia cells along erythroid, macrophage, and megakaryocyte lineages. Journal of Biological Response Modifiers 1986 5 3 250 262 2-s2.0-0022900640
23. Schwenke K., Peterson H.-P., Wangenheim K.-H., Feinendegen L. E., Induction of differentiation in erythroleukemic K562 cells by γ -irradiation. Leukemia Research 1995 19 12 955 961 2-s2.0-0029591557 10.1016/0145-2126(95)00096-8
24. Enujiugha V. N., Talabi J. Y., Malomo S. A., Olagunju A. I., DPPH radical scavenging capacity of phenolic extracts from African Yam Bean (Sphenostylis stenocarpa). Food and Nutrition Sciences 2012 3 7 13 10.4236/fns.2012.31002
25. Mijatovic S. A., Timotijevic G. S., Miljkovic D. M., Radovic J. M., Maksimovic-Ivanic D. D., Dekanski D. P., Stosic-Grujicic S. D., Multiple antimelanoma potential of dry olive leaf extract. International Journal of Cancer 2011 128 8 1955 1965 2-s2.0-79951971044 10.1002/ijc.25526
26. Abaza L., Talorete T. P. N., Yamada P., Kurita Y., Zarrouk M., Isoda H., Induction of growth inhibition and differentiation of human leukemia HL-60 cells by a Tunisian Gerboui olive leaf extract. Bioscience, Biotechnology and Biochemistry 2007 71 5 1306 1312 2-s2.0-34347407870 10.1271/bbb.60716
27. Tunca B., Tezcan G., Cecener G., Egeli U., Ak S., Malyer H., Tumen G., Bilir A., Olea europea leaf extract alters microRNA expression in human glioblastoma cells. Journal of Cancer Research and Clinical Oncology 2012 138 11 1831 1844
28. Matsuoka S., Huang M., Elledge S. J., Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 1998 282 5395 1893 1897 2-s2.0-0032484084
29. Frazer C., Young P. G., Huang C., Phosphorylation mediated regulation of Cdc25 activity, localization and stability. Protein Phosphorylation in Human Health 2012 InTech 395 436 10.5772/48315
30. Debili N., Robin C., Schiavon V., Letestu R., Pflumio F., Mitjavila-Garcia M.-T., Coulombel L., Vainchenker W., Different expression of CD41 on human lymphoid and myeloid progenitors from adults and neonates. Blood 2001 97 7 2023 2030 2-s2.0-0035312963 10.1182/blood.V97.7.2023
31. Nakajima H., Role of transcription factors in differentiation and reprogramming of hematopoietic cells. Keio Journal of Medicine 2011 60 2 47 55 2-s2.0-80051940892
32. Fukuchi Y., Shibata F., Ito M., Goto-Koshino Y., Sotomaru Y., Ito M., Kitamura T., Nakajima H., Comprehensive analysis of myeloid lineage conversion using mice expressing an inducible form of C/EBP α The EMBO Journal 2006 25 14 3398 3410 2-s2.0-33746493902 10.1038/sj.emboj.7601199
33. Shivdasani R. A., Molecular and transcriptional regulation of megakaryocyte differentiation. Stem Cells 2001 19 5 397 407 2-s2.0-0034812344
34. Terui K., Takahashi Y., Kitazawa J., Toki T., Yokoyama M., Ito E., Expression of transcription factors during megakaryocytic differentiation of CD34+ cells from human cord blood induced by thrombopoietin. Tohoku Journal of Experimental Medicine 2000 192 4 259 273 2-s2.0-0034578109 10.1620/tjem.192.259
35. Trapani J. A., Dawson M., Apostolidis V. A., Browne K. A., Genomic organization of IFI16, an interferon-inducible gene whose expression is associated with human myeloid cell differentiation: correlation of predicted protein domains with exon organization. Immunogenetics 1994 40 6 415 424 2-s2.0-0028130529
36. Dawson M. J., Elwood N. J., Johnstone R. W., Trapani J. A., The IFN-inducible nucleoprotein IFI 16 is expressed in cells of the monocyte lineage, but is rapidly and markedly down-regulated in other myeloid precursor populations. Journal of Leukocyte Biology 1998 64 4 546 554 2-s2.0-0031717656
37. Gariglio M., De Andrea M., Lembo M., Ravotto M., Zappador C., Valente G., Landolfo S., The murine homolog of the HIN 200 family, Ifi 204, is constitutively expressed in myeloid cells and selectively induced in the monocyte/macrophage lineage. Journal of Leukocyte Biology 1998 64 5 608 614 2-s2.0-0031762769
38. Valledor A. F., Borràs F. E., Cullell-Young M., Celada A., Transcription factors that regulate monocyte/macrophage differentiation. Journal of Leukocyte Biology 1998 63 4 405 417 2-s2.0-0031978804
39. Krishnaraju K., Hoffman B., Liebermann D. A., Early growth response gene 1 stimulates development of hematopoietic progenitor cells along the macrophage lineage at the expense of the granulocyte and erythroid lineages. Blood 2001 97 5 1298 1305 2-s2.0-0035283135 10.1182/blood.V97.5.1298
40. Dauffy J., Mouchiroud G., Bourette R. P., The interferon-inducible gene, Ifi204, is transcriptionally activated in response to M-CSF, and its expression favors macrophage differentiation in myeloid progenitor cells. Journal of Leukocyte Biology 2006 79 1 173 183 2-s2.0-30144438956 10.1189/jlb.0205083
41. Marziali G., Perrotti E., Ilari R., Testa U., Coccia E. M., Battistini A., Transcriptional regulation of the ferritin heavy-chain gene: the activity of the CCAAT binding factor NF-Y is modulated in heme-treated Friend leukemia cells and during monocyte-to-macrophage differentiation. Molecular and Cellular Biology 1997 17 3 1387 1395 2-s2.0-0031017966
42. Shi C., Zhang X., Chen Z., Sulaiman K., Feinberg M. W., Ballantyne C. M., Jain M. K., Simon D. I., Integrin engagement regulates monocyte differentiation through the forkhead transcription factor Foxp1. Journal of Clinical Investigation 2004 114 3 408 418 2-s2.0-4043073635 10.1172/JCI200421100
43. Shi C., Sakuma M., Mooroka T., Liscoe A., Gao H., Croce K. J., Sharma A., Kaplan D., Greaves D. R., Wang Y., Simon D. I., Down-regulation of the forkhead transcription factor Foxp1 is required for monocyte differentiation and macrophage function. Blood 2008 112 12 4699 4711 2-s2.0-58149386502 10.1182/blood-2008-01-137018
44. Smith D. F., Galkina E., Ley K., Huo Y., GRO family chemokines are specialized for monocyte arrest from flow. The American Journal of Physiology: Heart and Circulatory Physiology 2005 289 5 H1976 H1984 2-s2.0-27144545775 10.1152/ajpheart.00153.2005
45. Oppenheim J. J., Howard O. M. Z., Goetzl E., Chemotactic Factors, Neuropeptides, and Other Ligands for Seven Transmembrane Receptors 2000
46. Terashima Y., Onai N., Murai M., Enomoto M., Poonpiriya V., Hamada T., Motomura K., Suwa M., Ezaki T., Haga T., Kanegasaki S., Matsushima K., Pivotal function for cytoplasmic protein FROUNT in CCR2-mediated monocyte chemotaxis. Nature Immunology 2005 6 8 827 835 2-s2.0-23944454929 10.1038/ni1222
47. Lefkir Y., Malbouyres M., Gotthardt D., Ozinsky A., Cornillon S., Bruckert F., Aderem A. A., Soldati T., Cosson P., Letourneur F., Involvement of the AP-1 adaptor complex in early steps of phagocytosis and macropinocytosis. Molecular Biology of the Cell 2004 15 2 861 869 2-s2.0-0742322962 10.1091/mbc.E03-06-0365
48. Niedergang F., Chavrier P., Signaling and membrane dynamics during phagocytosis: many roads lead to the phagosome. Current Opinion in Cell Biology 2004 16 4 422 428 2-s2.0-3142514390 10.1016/j.ceb.2004.06.006
49. Cox D., Lee D. J., Dale B. M., Calafat J., Greenberg S., A Rab11-containing rapidly recycling compartment in macrophages that promotes phagocytosis. Proceedings of the National Academy of Sciences of the United States of America 2000 97 2 680 685 2-s2.0-0034681147 10.1073/pnas.97.2.680
50. Vieira O. V., Bucci C., Harrison R. E., Trimble W. S., Lanzetti L., Gruenberg J., Schreiber A. D., Stahl P. D., Grinstein S., Modulation of Rab5 and Rab7 recruitment to phagosomes by phosphatidylinositol 3-kinase. Molecular and Cellular Biology 2003 23 7 2501 2514 2-s2.0-0037378608 10.1128/MCB.23.7.2501- 2514.2003
51. Khurana T., Brzostowski J. A., Kimmel A. R., A Rab21/LIM-only/CH-LIM complex regulates phagocytosis via both activating and inhibitory mechanisms. The EMBO Journal 2005 24 13 2254 2264 2-s2.0-22744455266 10.1038/sj.emboj. 7600716
52. Martin S. J., Bradley J. G., Cotter T. G., HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clinical and Experimental Immunology 1990 79 3 448 453 2-s2.0-0025139398
53. Benito A., Grillot D., Nunez G., Fernandez-Luna J. L., Regulation and function of Bcl-2 during differentiation-induced cell death in HL-60 promyelocytic cells. The American Journal of Pathology 1995 146 2 481 490 2-s2.0-0028817069
54. Lamkanfi M., Festjens N., Declercq W., Berghe T. V., Vandenabeele P., Caspases in cell survival, proliferation and differentiation. Cell Death and Differentiation 2007 14 1 44 55 2-s2.0-33845483887 10.1038/sj.cdd.4402047
55. Sordet O., Rébé C., Plenchette S., Zermati Y., Hermine O., Vainchenker W., Garrido C., Solary E., Dubrez-Daloz L., Specific involvement of caspases in the differentiation of monocytes into macrophages. Blood 2002 100 13 4446 4453 2-s2.0-0037114624 10.1182/blood-2002-06-1778
56. Kang T.-B., Ben-Moshe T., Varfolomeev E. E., Pewzner-Jung Y., Yogev N., Jurewicz A., Waisman A., Brenner O., Haffner R., Gustafsson E., Ramakrishnan P., Lapidot T., Wallach D., Caspase-8 serves both apoptotic and nonapoptotic roles. Journal of Immunology 2004 173 5 2976 2984 2-s2.0-4344560197
57. Ichijo H., Nishida E., Irie K., Ten Dijke P., Saitoh M., Moriguchi T., Takagi M., Matsumoto K., Miyazono K., Gotoh Y., Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997 275 5296 90 94 2-s2.0-14444281569 10.1126/science.275.5296.90
58. Cheng J., Yang J., Xia Y., Karin M., Su B., Synergistic interaction of MEK kinase 2, c-Jun N-terminal kinase (JNK) kinase 2, and JNK1 results in efficient and specific JNK1 activation. Molecular and Cellular Biology 2000 20 7 2334 2342 2-s2.0-0034061264 10.1128/MCB.20.7.2334-2342.2000
59. Blank J. L., Gerwins P., Elliott E. M., Sather S., Johnson G. L., Molecular cloning of mitogen-activated protein/ERK kinase kinases (MEKK) 2 and 3 regulation of sequential phosphorylation pathways involving mitogen-activated protein kinase and c-Jun kinase. Journal of Biological Chemistry 1996 271 10 5361 5368 2-s2.0-0029913457
60. Papa S., Zazzeroni F., Pham C. G., Bubici C., Franzoso G., Linking JNK signaling to NF- B: a key to survival. Journal of Cell Science 2004 117 22 5197 5208 2-s2.0-9444245015 10.1242/jcs.01483
61. Kadoya T., Khurana A., Tcherpakov M., Bromberg K. D., Didier C., Broday L., Asahara T., Bhoumik A., Ronai Z., JAMP, a JUB N-terminal kinase 1 (JNK1)-associated membrane protein, regulates duration of JNK activity. Molecular and Cellular Biology 2005 25 19 8619 8630 2-s2.0-25444516196 10.1128/MCB.25.19.8619-8630.2005
62. Qi M., Elion E. A., MAP kinase pathways. Journal of Cell Science 2005 118 16 3569 3572 2-s2.0-24944553549 10.1242/jcs.02470
63. Zhao Q., Lee F. S., Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor- B through I B kinase- α and I B kinase- β The Journal of Biological Chemistry 1999 274 13 8355 8358 2-s2.0-0033605575 10.1074/jbc.274.13.8355
64. Namba H., Saenko V., Yamashita S., Nuclear factor- B in thyroid carcinogenesis and progression: a novel therapeutic target for advanced thyroid cancer. Arquivos Brasileiros de Endocrinologia e Metabologia 2007 51 5 843 851 2-s2.0-35348816753
65. Feng B., Cheng S., Pear W. S., Liou H.-C., NF-kB inhibitor blocks B cell development at two checkpoints. Medical Immunology 2004 3, article 1 2-s2.0-2942598309 10.1186/1476-9433-3-1
66. Gerondakis S., Siebenlist U., Roles of the NF-kappaB pathway in lymphocyte development and function. Cold Spring Harbor Perspectives in Biology 2010 2 5 a000182 2-s2.0-77955288093 10.1101/cshperspect.a000182
67. Bhat K. P., Balasubramaniyan V., Vaillant B., Mesenchymal differentiation mediated by NF-kB promotes radiation resistance in glioblastoma. Cancer Cell 2013 24 3 331 346 10.1016/j.ccr.2013.08.001